Threat to Cefixime Treatment for Gonorrhea
- 1 August 2007
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (8) , 1275-1277
- https://doi.org/10.3201/eid1308.060948
Abstract
Threat to Cefixime Treatment for GonorrheaKeywords
This publication has 9 references indexed in Scilit:
- Amino Acid Substitutions in Mosaic Penicillin-Binding Protein 2 Associated with Reduced Susceptibility to Cefixime in Clinical Isolates of Neisseria gonorrhoeaeAntimicrobial Agents and Chemotherapy, 2006
- Sexually transmitted diseases treatment guidelines, 2006.2006
- Nonfatal, unintentional medication exposures among young children--United States, 2001-2003.2006
- Emergence and Spread of Neisseria gonorrhoeae Clinical Isolates Harboring Mosaic-Like Structure of Penicillin-Binding Protein 2 in Central JapanAntimicrobial Agents and Chemotherapy, 2005
- Multidrug‐ResistantNeisseria gonorrhoeaewith Decreased Susceptibility to Cefixime—Hawaii, 2001Clinical Infectious Diseases, 2003
- Treatment of uncomplicated gonococcal urethritis by double-dosing of 200mg cefixime at a 6-h intervalJournal of Infection and Chemotherapy, 2003
- Mosaic-Like Structure of Penicillin-Binding Protein 2 Gene ( penA ) in Clinical Isolates of Neisseria gonorrhoeae with Reduced Susceptibility to CefiximeAntimicrobial Agents and Chemotherapy, 2002
- Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typingJournal of Clinical Microbiology, 1995